查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1829412

2025年膽紅素血液檢測全球市場報告

Bilirubin Blood Test Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，膽紅素血液檢測市場規模強勁成長，從2024年的13.7億美元增加至2025年的14.6億美元，複合年成長率為6.9%。預測期內的成長可歸因於肝病盛行率的上升、新生兒照護的普及、技術進步、健康意識的增強、醫療基礎設施的改善、監管部門的核准和指南的製定，以及就地檢驗的普及。

預計未來幾年膽紅素血液檢測市場規模將強勁成長，到2029年將達到19.4億美元，複合年成長率為7.4%。預測期內的成長動力包括：早期診斷需求的不斷成長、診斷實驗室的擴張、慢性病盛行率的上升、新興市場的成長、高級分析技術的整合以及研究資金的增加。預測期內的主要趨勢包括：非侵入性檢測方法的開發、與數位健康解決方案的整合、家用檢測套組的進步、檢測準確性和速度的提高、個人化醫療方法以及智慧診斷和攜帶式設備的發展。

膽紅素血液檢測是一種測量血液中膽紅素濃度的診斷程序。此檢測對於評估肝功能以及診斷黃疸和肝病等疾病至關重要。它對於評估膽紅素代謝和識別肝臟健康問題至關重要。

膽紅素血液檢測的主要類型包括總血清膽紅素檢測、間接或非結合膽紅素檢測以及直接或結合膽紅素檢測。總血清膽紅素檢測測量血液中非結合（間接）膽紅素和結合（直接）膽紅素的總合。此檢測對於全面評估肝臟健康狀況和診斷各種肝臟相關疾病至關重要。此檢測適用於成人、兒童和嬰兒，並可在醫院、診所和其他醫療機構使用。

2025年春季美國關稅的突然上調及其引發的貿易摩擦對醫療設備行業產生了重大影響，尤其對用於診斷影像設備的進口零件、手術用不銹鋼和一次性塑膠製品產生了重大影響。由於醫院和診所抵制漲價，製造商面臨利潤壓力。監管挑戰使情況更加複雜，因為由於關稅而更換供應商通常需要重新認證醫療設備，導致市場進入延遲。為此，企業正在透過雙重採購關鍵零件、增加標準化產品的國內生產以及加快尋找更具成本效益的材料來降低風險。

本研究報告隸屬於一家商業研究公司發布的一系列新報告，提供膽紅素血液檢測市場統計數據，包括全球市場規模、各地區市場佔有率、競爭對手的膽紅素血液檢測市場佔有率、詳細的膽紅素血液檢測細分市場、市場趨勢和商機，以及您在膽紅素血液檢測行業取得成功所需的數據。本膽紅素血液檢測市場研究報告對該行業的現狀和未來趨勢進行了詳細分析，為您提供全面的觀點。

未來五年7.4%的預測成長率，較我們先前對該市場的預測略有下降0.1%。這一下降主要源自於美國與其他國家之間關稅的影響。該影響將透過對瑞典和加拿大的光度測定組件和試劑徵收關稅直接影響美國，這可能會增加新生兒黃疸篩檢的成本，並影響兒科護理的可負擔性。此外，互惠關稅以及貿易緊張局勢和限制加劇對全球經濟和貿易的負面影響也將更廣泛地反映出來。

肝病盛行率的不斷上升預計將推動膽紅素血液檢測市場的成長。肝病涵蓋多種會嚴重損害肝功能的疾病，通常由感染疾病、過量飲酒和代謝紊亂等因素引起。肝病盛行率的上升與肥胖率上升、酗酒、病毒感染和不健康的生活方式有關，所有這些因素都會導致肝損傷和肝功能障礙。由於肝病會顯著改變體內膽紅素水平，因此膽紅素血液檢測對於診斷和監測肝功能至關重要。這些檢測能夠提供寶貴的臨床訊息，幫助醫生了解患者的健康狀況，並協助其管理肝臟相關疾病。例如，歐洲疾病預防控制中心於2024年4月報告稱，2022年歐盟/歐洲經濟區30個成員國共有28,855例乙型肝炎病毒(HBV)感染病例，較2021年的16,187例增加了78%。 2022年的盛行率為每10萬人8.5例。肝病盛行率的上升預計將推動膽紅素血液檢測市場的發展。

膽紅素血液檢測市場的主要企業正在建立策略夥伴關係關係，以擴大其市場範圍並增強其產品供應。策略夥伴關係是組織之間的合作，它結合資源和專業知識以實現共同目標。例如，2023 年 12 月，以色列醫療診斷生物技術公司 Calmark Sweden AB 與沙烏地阿拉伯的 Techno Orbits 簽署了新生兒膽紅素檢測的獨家經銷協議。 Techno Orbits 將利用其已建立的網路和關係（包括與衛生署）來管理 Calmark 產品的分銷和銷售。此次夥伴關係旨在加快將 Calmark 的膽紅素檢測引入沙烏地阿拉伯市場，預計監管註冊需要三到六個月。

2023年12月，中國醫療科技公司深圳邁瑞生物醫療電子股份有限公司收購了德國德賽診斷系統有限公司（DiaSys Diagnostic Systems GmbH）75%的股份，收購金額未揭露。此次收購旨在利用德賽成熟的供應鏈和臨床化學專業知識，增強邁瑞在體外診斷 (IVD) 領域的競爭地位。預計此次收購將增強邁瑞服務中大型客戶的能力，並提升其服務水準。德賽診斷系統有限公司總部位於德國，專注於肝病膽紅素血液檢測等診斷系統。

膽紅素血液檢測市場涵蓋測量膽紅素水平的診斷設備的銷售，包括檢測套組、血液分析儀和自動化檢測系統。該市場的價值是指“出廠價”，即商品製造商或生產者向其他營業單位（包括下游製造商、批發商、經銷商和零售商）或直接向最終客戶銷售的商品價值。該市場中的商品價值還包括商品生產者銷售的任何相關服務。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、貿易戰和關稅，以及新冠疫情和復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球膽紅素血液檢測：PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球膽紅素血液檢測市場：成長率分析
  • 全球膽紅素血液檢測市場表現：規模與成長，2019-2024
  • 全球膽紅素血液檢測市場預測：規模與成長，2024-2029，2034
  • 全球膽紅素血液檢測：總目標市場（TAM）

第6章 市場細分

  • 全球膽紅素血液檢測市場（按檢測類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 血清總膽紅素檢測
  • 間接或非結合膽紅素檢測
  • 直接膽紅素檢測或結合膽紅素檢測
  • 全球膽紅素血液檢測市場：依年齡層、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 成人
  • 孩子們
  • 嬰兒
  • 全球膽紅素血液檢測市場：應用、績效及預測，2019-2024年、2024-2029年、2034年
  • 醫院
  • 診所
  • 其他用途
  • 全球膽紅素血液檢測市場：依總血清膽紅素檢測細分（按類型）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 定期檢查
  • 肝功能評估
  • 新生兒黃疸檢測
  • 全球膽紅素血液檢測市場：細分：間接或非結合膽紅素檢測、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 溶血性貧血的診斷
  • 檢測吉爾伯特症候群
  • 監測已有的肝病
  • 全球膽紅素血液檢測市場：按類型細分（直接膽紅素檢測或結合膽紅素檢測）、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 膽管阻塞的診斷
  • 肝炎和肝病監測
  • 肝病後評估

第7章 區域和國家分析

  • 全球膽紅素血液檢測市場：按地區、績效和預測，2019-2024 年、2024-2029 年、2034 年
  • 全球膽紅素血液檢測市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

  • 膽紅素血液檢測市場：競爭格局
  • 膽紅素血液檢測市場：公司簡介
    • F.Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

  • Koninklijke Philips NV
  • Mindray Medical International Limited
  • Beckman Coulter Inc.
  • Dragerwerk AG and Co. KGaA
  • Sysmex Corporation
  • Bio-Rad Laboratories Inc.
  • Konica Minolta Inc.
  • Instrumentation Laboratory LLC
  • Randox Laboratories Ltd.
  • Ortho Clinical Diagnostics Inc.
  • Natus Medical Incorporated
  • Nova Biomedical
  • Advanced Instruments LLC
  • Helmer Scientific Inc.
  • Reichert Technologies Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章：高潛力市場國家、細分市場與策略

  • 2029年膽紅素血液檢測市場：提供新機會的國家
  • 2029 年膽紅素血液檢測市場：細分市場帶來新機會
  • 2029年膽紅素血液檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第36章 附錄

簡介目錄
Product Code: r29586u

The bilirubin blood test is a diagnostic procedure used to measure bilirubin levels in the blood. This test is important for evaluating liver function and diagnosing conditions such as jaundice and liver disease. It is crucial for assessing bilirubin metabolism and identifying liver health issues.

The main types of bilirubin blood tests includes the total serum bilirubin test, the indirect or unconjugated bilirubin test, and the direct or conjugated bilirubin test. The total serum bilirubin test measures the combined amount of unconjugated (indirect) and conjugated (direct) bilirubin in the blood. This test is essential for assessing overall liver health and diagnosing various liver-related conditions. The test is applicable to adults, pediatrics, and infants, and it is used in hospitals, clinics, and other healthcare settings.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp increase in U.S. tariffs and resulting trade tensions in spring 2025 are significantly impacting the medical equipment sector, especially for imported components used in imaging machines, surgical-grade stainless steel, and disposable plastics. With hospitals and clinics pushing back against price increases, manufacturers are facing margin pressure. The situation is further complicated by regulatory challenges, as switching suppliers due to tariffs often necessitates re-certification of medical devices, leading to delays in market entry. In response, companies are mitigating risks by dual-sourcing key components, ramping up domestic production of standardized items, and accelerating research into more cost-effective materials.

The bilirubin blood test market research report is one of a series of new reports from the business research company that provides bilirubin blood test market statistics, including bilirubin blood test industry global market size, regional shares, competitors with an bilirubin blood test market share, detailed bilirubin blood test market segments, market trends and opportunities, and any further data you may need to thrive in the bilirubin blood test industry. This bilirubin blood test market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bilirubin blood test market size has grown strongly in recent years. It will grow from $1.37 billion in 2024 to $1.46 billion in 2025 at a compound annual growth rate (CAGR) of 6.9%. The growth in the historic period can be attributed to the increasing prevalence of liver diseases, growth in neonatal care, technological advancements, rising health awareness, healthcare infrastructure development, regulatory approvals and guidelines, and increased adoption of point-of-care testing.

The bilirubin blood test market size is expected to see strong growth in the next few years. It will grow to $1.94 billion in 2029 at a compound annual growth rate (CAGR) of 7.4%. The growth in the forecast period can be attributed to growing demand for early diagnosis, expansion of diagnostic laboratories, rising incidence of chronic diseases, emerging markets growth, integration of advanced analytics, increased research funding. Major trends in the forecast period include development of non-invasive testing methods, integration with digital health solutions, advances in home testing kits, enhanced test accuracy and speed, personalized medicine approaches, smart diagnostic devices, development of portable devices.

The forecast of 7.4% growth over the next five years indicates a slight reduction of 0.1% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through tariffs on photometric components and reagents from Sweden and Canada, increasing the cost of neonatal jaundice screening and impacting pediatric care affordability.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of liver diseases is anticipated to drive the growth of the bilirubin blood test market. Liver diseases encompass a variety of conditions that impair the liver's ability to function effectively, often due to factors such as infections, excessive alcohol consumption, or metabolic disorders. The rise in liver disease cases is linked to escalating obesity rates, high alcohol intake, viral infections, and unhealthy lifestyle choices, all of which contribute to liver damage and dysfunction. Since liver disease can significantly alter bilirubin levels in the body, bilirubin blood tests are essential for diagnosing and monitoring liver function. These tests provide valuable insights into patient health and support healthcare providers in managing liver-related conditions. For example, the European Centre for Disease Prevention and Control reported in April 2024 that there were 28,855 cases of hepatitis B virus (HBV) infection across 30 EU/EEA Member States in 2022, marking a 78% increase from 16,187 cases in 2021. The 2022 cases amounted to a crude rate of 8.5 cases per 100,000 people. This rising incidence of liver diseases is expected to boost the bilirubin blood test market.

Leading companies in the bilirubin blood test market are increasingly forming strategic partnerships to broaden their reach and improve their offerings. A strategic partnership involves a collaborative relationship between organizations that combines resources and expertise to achieve mutual goals. For example, in December 2023, Calmark Sweden AB, an Israel-based medical diagnostic biotechnology firm, entered into an exclusive distributor agreement with Techno Orbits in Saudi Arabia for its bilirubin test for newborns. Techno Orbits will manage the distribution and sales of Calmark's product, utilizing its established network and connections, including with the Ministry of Health. This partnership aims to facilitate the introduction of Calmark's bilirubin test into the Saudi market, with regulatory registration expected to take between 3 to 6 months.

In December 2023, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., a China-based medical technology provider, acquired a 75% stake in DiaSys Diagnostic Systems GmbH for an undisclosed sum. This acquisition is designed to bolster Mindray's competitive position in the in vitro diagnostic (IVD) sector by leveraging DiaSys's established supply chains and expertise in clinical chemistry. The acquisition is expected to enhance Mindray's capabilities in serving medium- to large-volume customers and improve service delivery. DiaSys Diagnostic Systems GmbH, based in Germany, specializes in diagnostic systems, including bilirubin blood tests for liver diseases.

Major companies operating in the bilirubin blood test market are F.Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Mindray Medical International Limited, Beckman Coulter Inc., Dragerwerk AG and Co. KGaA, Sysmex Corporation, Bio-Rad Laboratories Inc., Konica Minolta Inc., Instrumentation Laboratory LLC, Randox Laboratories Ltd., Ortho Clinical Diagnostics Inc., Natus Medical Incorporated, Nova Biomedical, Advanced Instruments LLC, Helmer Scientific Inc., Reichert Technologies Inc., Rousselet Robatel SAS, Labnet International Inc., AVI Healthcare Pvt. Ltd., Ginevri S.p.A.

North America was the largest region in the bilirubin blood test market in 2024. The regions covered in the bilirubin blood test market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bilirubin blood test market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bilirubin blood test market consists of sales of products such as diagnostic devices for measuring bilirubin levels, including test kits, blood analyzers, and automated testing systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bilirubin Blood Test Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bilirubin blood test market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bilirubin blood test ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bilirubin blood test market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Test Type: Total Serum Bilirubin Test; Indirect Or Unconjugated Bilirubin Test; Direct Or Conjugated Bilirubin Test
  • 2) By Age Group: Adults; Pediatrics; Infants
  • 3) By Application: Hospital; Clinic; Other Applications
  • Subsegments:
  • 1) By Total Serum Bilirubin Test: Routine Screening; Liver Function Assessment; Newborn Jaundice Detection
  • 2) By Indirect Or Unconjugated Bilirubin Test: Hemolytic Anemia Diagnosis; Gilbert's Syndrome Detection; Monitoring For Preliver Conditions
  • 3) By Direct Or Conjugated Bilirubin Test: Bile Duct Obstruction Diagnosis; Hepatitis And Liver Disease Monitoring; Post-Liver Condition Assessment
  • Companies Mentioned: F.Hoffmann-La Roche Ltd; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; Mindray Medical International Limited; Beckman Coulter Inc.; Dragerwerk AG and Co. KGaA; Sysmex Corporation; Bio-Rad Laboratories Inc.; Konica Minolta Inc.; Instrumentation Laboratory LLC; Randox Laboratories Ltd.; Ortho Clinical Diagnostics Inc.; Natus Medical Incorporated; Nova Biomedical; Advanced Instruments LLC; Helmer Scientific Inc.; Reichert Technologies Inc.; Rousselet Robatel SAS; Labnet International Inc.; AVI Healthcare Pvt. Ltd.; Ginevri S.p.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bilirubin Blood Test Market Characteristics

3. Bilirubin Blood Test Market Trends And Strategies

4. Bilirubin Blood Test Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Bilirubin Blood Test Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Bilirubin Blood Test PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Bilirubin Blood Test Market Growth Rate Analysis
  • 5.4. Global Bilirubin Blood Test Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Bilirubin Blood Test Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Bilirubin Blood Test Total Addressable Market (TAM)

6. Bilirubin Blood Test Market Segmentation

  • 6.1. Global Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Total Serum Bilirubin Test
  • Indirect Or Unconjugated Bilirubin Test
  • Direct Or Conjugated Bilirubin Test
  • 6.2. Global Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adults
  • Pediatrics
  • Infants
  • 6.3. Global Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospital
  • Clinic
  • Other Applications
  • 6.4. Global Bilirubin Blood Test Market, Sub-Segmentation Of Total Serum Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Routine Screening
  • Liver Function Assessment
  • Newborn Jaundice Detection
  • 6.5. Global Bilirubin Blood Test Market, Sub-Segmentation Of Indirect Or Unconjugated Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hemolytic Anemia Diagnosis
  • Gilbert's Syndrome Detection
  • Monitoring For Preliver Conditions
  • 6.6. Global Bilirubin Blood Test Market, Sub-Segmentation Of Direct Or Conjugated Bilirubin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Bile Duct Obstruction Diagnosis
  • Hepatitis And Liver Disease Monitoring
  • Post-Liver Condition Assessment

7. Bilirubin Blood Test Market Regional And Country Analysis

  • 7.1. Global Bilirubin Blood Test Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Bilirubin Blood Test Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bilirubin Blood Test Market

  • 8.1. Asia-Pacific Bilirubin Blood Test Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bilirubin Blood Test Market

  • 9.1. China Bilirubin Blood Test Market Overview
  • 9.2. China Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bilirubin Blood Test Market

  • 10.1. India Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bilirubin Blood Test Market

  • 11.1. Japan Bilirubin Blood Test Market Overview
  • 11.2. Japan Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bilirubin Blood Test Market

  • 12.1. Australia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bilirubin Blood Test Market

  • 13.1. Indonesia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bilirubin Blood Test Market

  • 14.1. South Korea Bilirubin Blood Test Market Overview
  • 14.2. South Korea Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bilirubin Blood Test Market

  • 15.1. Western Europe Bilirubin Blood Test Market Overview
  • 15.2. Western Europe Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bilirubin Blood Test Market

  • 16.1. UK Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bilirubin Blood Test Market

  • 17.1. Germany Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bilirubin Blood Test Market

  • 18.1. France Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bilirubin Blood Test Market

  • 19.1. Italy Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bilirubin Blood Test Market

  • 20.1. Spain Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bilirubin Blood Test Market

  • 21.1. Eastern Europe Bilirubin Blood Test Market Overview
  • 21.2. Eastern Europe Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bilirubin Blood Test Market

  • 22.1. Russia Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bilirubin Blood Test Market

  • 23.1. North America Bilirubin Blood Test Market Overview
  • 23.2. North America Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bilirubin Blood Test Market

  • 24.1. USA Bilirubin Blood Test Market Overview
  • 24.2. USA Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bilirubin Blood Test Market

  • 25.1. Canada Bilirubin Blood Test Market Overview
  • 25.2. Canada Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bilirubin Blood Test Market

  • 26.1. South America Bilirubin Blood Test Market Overview
  • 26.2. South America Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bilirubin Blood Test Market

  • 27.1. Brazil Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bilirubin Blood Test Market

  • 28.1. Middle East Bilirubin Blood Test Market Overview
  • 28.2. Middle East Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bilirubin Blood Test Market

  • 29.1. Africa Bilirubin Blood Test Market Overview
  • 29.2. Africa Bilirubin Blood Test Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Bilirubin Blood Test Market, Segmentation By Age Group, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Bilirubin Blood Test Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bilirubin Blood Test Market Competitive Landscape And Company Profiles

  • 30.1. Bilirubin Blood Test Market Competitive Landscape
  • 30.2. Bilirubin Blood Test Market Company Profiles
    • 30.2.1. F.Hoffmann-La Roche Ltd Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

31. Bilirubin Blood Test Market Other Major And Innovative Companies

  • 31.1. Koninklijke Philips N.V.
  • 31.2. Mindray Medical International Limited
  • 31.3. Beckman Coulter Inc.
  • 31.4. Dragerwerk AG and Co. KGaA
  • 31.5. Sysmex Corporation
  • 31.6. Bio-Rad Laboratories Inc.
  • 31.7. Konica Minolta Inc.
  • 31.8. Instrumentation Laboratory LLC
  • 31.9. Randox Laboratories Ltd.
  • 31.10. Ortho Clinical Diagnostics Inc.
  • 31.11. Natus Medical Incorporated
  • 31.12. Nova Biomedical
  • 31.13. Advanced Instruments LLC
  • 31.14. Helmer Scientific Inc.
  • 31.15. Reichert Technologies Inc.

32. Global Bilirubin Blood Test Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bilirubin Blood Test Market

34. Recent Developments In The Bilirubin Blood Test Market

35. Bilirubin Blood Test Market High Potential Countries, Segments and Strategies

  • 35.1 Bilirubin Blood Test Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Bilirubin Blood Test Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Bilirubin Blood Test Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer